Phreesia Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>PH</div>
PHR -- USA Stock  

USD 32.13  1.19  3.85%

While many traders are getting carried away by overanalyzing healthcare space, it is reasonable to sum up Phreesia. What exactly are Phreesia shareholders getting in October? Here I will also expose some primary fundamental factors affecting Phreesia's services, and outline how it will impact the outlook for investors this year.
Published over three weeks ago
View all stories for Phreesia | View All Stories
Is Phreesia (NYSE:PHR) ripping up retail investors?
This firm reported the last year's revenue of 129.87 M. Reported Net Loss for the year was (82.98 M) with profit before taxes, overhead, and interest of 80.06 M.

How important is Phreesia's Liquidity

Phreesia financial leverage refers to using borrowed capital as a funding source to finance Phreesia ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Phreesia financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Phreesia's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Phreesia, but it might be worth checking our own buy vs. sell analysis

What is driving Phreesia Investor Appetite?

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Phreesia has an asset utilization ratio of 203.67 percent. This connotes that the company is making $2.04 for each dollar of assets. An increasing asset utilization means that Phreesia is more efficient with each dollar of assets it utilizes for everyday operations.

Will Phreesia continue to go crazy?

The market risk adjusted performance is down to 4.47 as of today. As of the 7th of September, Phreesia holds the Coefficient Of Variation of 2111.11, risk adjusted performance of 0.5613, and Semi Deviation of 2.98. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Phreesia, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Phreesia, which can be compared to its competitors. Please check Phreesia information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Phreesia is priced some-what accurately, providing market reflects its current price of 31.0 per share. Given that Phreesia has jensen alpha of 0.1833, we recommend you to check out Phreesia's recent market performance to make sure the company can sustain itself at a future point.

The Bottom Line

While some other companies in the health information services industry are either recovering or due for a correction, Phreesia may not be as strong as the others in terms of longer-term growth potentials. On the whole, as of the 7th of September 2020, our up-to-date 30 days buy-or-sell advice on the enterprise is Hold. We believe Phreesia is currently fairly valued with very low chance of bankruptcy for the next two years.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Phreesia. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com